March 2026 - Page 27 of 27

MondayMar 02, 2026 9:45 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on developing novel treatments for primary and metastatic cancers of the brain and central nervous system, announced the appointment of Lynne Kelley, MD, FACS, as Chief Medical Officer. Dr. Kelley brings more than 20 years of global leadership experience spanning clinical development, translational medicine and regulatory strategy across oncology, rare diseases, CNS and medical devices, having led Phase 1–3 programs and supported regulatory approvals in the United States, Europe, China and Japan. She has previously served as chief medical officer at several biotechnology and medical device companies, including TISSIUM, Servier Pharmaceuticals, X4…

MondayMar 02, 2026 9:30 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Completes $1M AI Edge System Delivery to U.S. Government in 15 Days

Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security and situational awareness solutions, announced it completed full delivery of its $1,000,000 AI-powered edge processing systems to the U.S. Government within 15 days of receiving the award. The Company said the rapid execution marks an operational milestone as it advances commercialization of its patented AI product portfolio and strengthens its past performance record under U.S. Government programs. Management noted the achievement reinforces confidence in Safe Pro’s ability to deliver under government contracts, while the Company continues pursuing additional opportunities with U.S. agencies, prime contractors and allied international partners. To…

MondayMar 02, 2026 9:27 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Appoints Matt McCrann As CEO Of U.S. Subsidiary

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0), developer of the Overwatch GPS-denied navigation and targeting platform, has appointed Matt McCrann as Chief Executive Officer of its U.S. subsidiary to lead North American expansion and deepen engagement with U.S. defense, federal and allied government customers. McCrann previously served as CEO of DroneShield’s U.S. subsidiary, where he established and scaled operations during a period of significant revenue growth across federal markets. In his new role, he will focus on building U.S. operational infrastructure, advancing field evaluations and pilot programs, aligning with procurement pathways and forming partnerships…

MondayMar 02, 2026 9:20 am

QualityStocksNewsBreaks – Renewal Fuels, Inc. (OTC: RNWF) Closes Kepler Fusion Transaction, Advances SEC Reporting and American Fusion Transition

Renewal Fuels (OTC: RNWF) announced that all closing conditions related to its previously disclosed transaction with Kepler Fusion Technologies Inc. have been satisfied, formally closing the transaction effective Feb. 27, 2026, for accounting purposes. The definitive closing date supports purchase price accounting clarity and simplifies the Company’s fiscal 2025 year-end audit, which is nearing completion. Management said the completion enables finalization of acquisition accounting and related disclosures as the Company progresses toward full SEC reporting status. Separately, Renewal Fuels refiled its Motion for Entry of Default Judgment in a pending Washington matter with additional specificity requested by the court. The…

MondayMar 02, 2026 9:10 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints Prof. Joshua C. Brown As Chief Medical Innovation Officer

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has appointed Prof. Joshua C. Brown, MD, PhD, as Chief Medical Innovation Officer. Prof. Brown is a psychiatrist, neurologist and neuroscientist who studies the mechanisms of Transcranial Magnetic Stimulation (TMS) and their translation into clinical optimization. He serves as Medical Director of the McLean Hospital TMS Service, Director of TMS research and founding director of the Brain Stimulation Mechanisms Laboratory, with more than $20 million in federal funding from the National Institute of Mental Health and the Defense Advanced Research Projects Agency. At NRx, he will support development of mechanistically informed neuropsychiatric…

MondayMar 02, 2026 9:00 am

Liora, a subsidiary of LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), Introduces New CEO, Brings Experience to Treating Tumors with Proton Therapy

There are several types of technologies for treating tumors with proton therapy, such as pencil beam scanning, passive scattering, and others Linac for Image Guided Hadron Therapy, LiGHT system, is believed to offer a more affordable, compact, and efficient design, along with better treatment precision than traditional technologies The system complements LIXTE’s lead clinical candidate, LB-100, which is a small-molecule PP2A inhibitor which is designed to enhance the activity of immunotherapy and chemotherapy Treating tumors with proton therapy is a highly advanced form of radiation that offers high precision, which minimizes radiation exposure for the tissue around the tumor. There…

MondayMar 02, 2026 9:00 am

QualityStocksNewsBreaks – MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Commences Second Natural Hydrogen Well At Grasslands Project

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) has commenced drilling of a second Natural Hydrogen well, “Bracken,” approximately 325 km southwest of the Lawson Discovery near Central Butte, Saskatchewan. The well will test basin-scale continuity under a distinct stratigraphic trapping mechanism at the Grasslands Project, part of the Company’s 1.3 million permitted acres. Bracken targets the interpreted pinch-out of a large reservoir based on 34.3 line kilometres of newly acquired proprietary 2-D seismic data combined with legacy seismic. The location also sits…

Site Search

Company Search

Month: March 2026